Kerget, B. Et Al. 2024. Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.41, no.4 , 1-7.

Kerget, B., Topal, B. N., Çınar, İ., Alper, F., & Sağlam, L., (2024). Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.41, no.4, 1-7.

Kerget, Buğra Et Al. "Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19," SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.41, no.4, 1-7, 2024

Kerget, Buğra Et Al. "Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.41, no.4, pp.1-7, 2024

Kerget, B. Et Al. (2024) . "Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19." SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , vol.41, no.4, pp.1-7.

@article{article, author={Buğra KERGET Et Al. }, title={Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis Due to COVID-19}, journal={SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES}, year=2024, pages={1-7} }